Amdocs responds to short seller report containing inaccurate statements, groundless claims and speculation
02 April 2021 - 12:19AM
Amdocs Limited (NASDAQ: DOX) (“Amdocs” or the “Company”), today
commented on a short seller report published yesterday, March 31,
2021 by Jehoshaphat Research:
|
The report contains inaccurate statements, groundless claims and
speculation that were designed to drive the stock price downwards
to serve the short seller’s interests to the detriment of Amdocs
shareholders. We remain fully confident in our accounting and
business practices. We caution shareholders from making investment
decisions based on this report.Amdocs delivered record revenue of
more than $4.2B for the full fiscal year 2020, with stable non-GAAP
operating margins. Our financial outlook remains strong.Amdocs is
well positioned to continue to benefit from secular trends driving
customer demand for digital modernization solutions, particularly
in the adoption of 5G technology and the journey to the cloud. We
are continuously expanding our leading position with our key
customers across the world and we are proud of our track record of
meeting global customer commitments, building on our base of
stable, recurring revenues and delivering shareholder value.We
continue to communicate directly with our investors regarding the
short seller’s report and we will provide more detailed information
next week. |
About AmdocsAmdocs’ purpose is to enrich
lives and progress society, using creativity and technology to
build a better connected world. Amdocs and its 26,000
employees partner with the leading players in the communications
and media industry, enabling next-generation experiences in 85
countries. Our cloud-native, open and dynamic portfolio of digital
solutions, platforms and services brings greater choice, faster
time to market and flexibility, to better meet the evolving needs
of our customers as they drive growth, transform and take their
business to the cloud. Listed on the NASDAQ Global Select
Market, Amdocs had revenue of $4.2 billion in
fiscal 2020.
For more information, visit Amdocs at www.amdocs.com.
Forward looking statement This press release
includes information that constitutes forward-looking statements
made pursuant to the safe harbor provision of the Private
Securities Litigation Reform Act of 1995, including statements
about Amdocs’ growth and business results in future quarters.
Although we believe the expectations reflected in such
forward-looking statements are based upon reasonable assumptions,
we can give no assurance that our expectations will be obtained or
that any deviations will not be material. Such statements involve
risks and uncertainties that may cause future results to differ
from those anticipated. These risks include, but are not limited
to, the effects of general economic conditions, the duration and
severity of the COVID-19 pandemic, and its impact on the global
economy, Amdocs’ ability to grow in the business markets that it
serves, Amdocs’ ability to successfully integrate acquired
businesses, adverse effects of market competition, rapid
technological shifts that may render the Company’s products and
services obsolete, potential loss of a major customer, our ability
to develop long-term relationships with our customers, and risks
associated with operating businesses in the international
market. Amdocs may elect to update these forward-looking
statements at some point in the future;
however, Amdocs specifically disclaims any obligation to
do so. These and other risks are discussed at greater length in
Amdocs’ filings with the Securities and Exchange Commission,
including in our Annual Report on Form 20-F for the fiscal year
ended September 30, 2020 filed on December 14, 2020
and our Form 6-K furnished for the first quarter of fiscal 2021 on
February 16, 2021.
Contact: Matthew SmithHead of Investor
RelationsAmdocsTel: +1 (314) 212-8328E-mail:
dox_info@amdocs.com
Amdocs (NASDAQ:DOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amdocs (NASDAQ:DOX)
Historical Stock Chart
From Jul 2023 to Jul 2024